Closed-loop nonlinear smooth robust control of anti-angiogenic tumor therapy

This paper presents a smooth robust controller for anti-angiogenic treatment of a tumor growth. The proposed control algorithm directly aims to drive the carrying capacity of the vascular support network to a desired trajectory that reduces overall tumor volume. For this aim, we present a closed-loop smooth robust controller that ensures the asymptotic tracking of a time-varying carrying capacity profile, despite the model uncertainties. A Lyapunov-based analysis approach is used to determine stability and performance results. Numerical simulation results are presented to demonstrate the performance and feasibility of the proposed approach. Simulation studies also examine some practical issues regarding the clinical application of the proposed dosing algorithm. Finally, the paper provides some basics for real-time implementation of the overall system.

[1]  Darren M. Dawson,et al.  A Continuous Control Mechanism for Uncertain Nonlinear Systems , 2004 .

[2]  Shay Soker,et al.  VEGF/VPF: The angiogenesis factor found? , 1993, Current Biology.

[3]  Alberto Gandolfi,et al.  Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999). , 2004, Mathematical biosciences.

[4]  J. Folkman,et al.  Angiogenesis Inhibitors Generated by Tumors , 1995, Molecular medicine.

[5]  Urszula Ledzewicz,et al.  Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis. , 2008, Journal of theoretical biology.

[6]  H. Schättler,et al.  A Synthesis of Optimal Controls for a Model of Tumor Growth under Angiogenic Inhibitors , 2005, Proceedings of the 44th IEEE Conference on Decision and Control.

[7]  N Nath,et al.  Optimizing antiangiogenic therapy for tumor minimization , 2010, Proceedings of the 2010 American Control Conference.

[8]  Helen M Byrne,et al.  A multiphase model describing vascular tumour growth , 2003, Bulletin of mathematical biology.

[9]  Matthew E. Pepper,et al.  Building off-the-shelf tissue-engineered composites , 2010, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[10]  P. Hahnfeldt,et al.  Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy. , 1999, Cancer research.

[11]  Urszula Ledzewicz,et al.  Minimizing Tumor Volume for a Mathematical Model of Anti-Angiogenesis with Linear Pharmacokinetics , 2010 .

[12]  U. Ledzewicz Optimal Control for a System Modelling Tumor Anti-Angiogenesis , 2006 .

[13]  Trachette L. Jackson,et al.  Vascular tumor growth and treatment: Consequences of polyclonality, competition and dynamic vascular support , 2002, Journal of mathematical biology.

[14]  M. Chaplain,et al.  Continuous and Discrete Mathematical Models of Tumor‐Induced Angiogenesis , 1999 .

[15]  Alberto Gandolfi,et al.  A family of models of angiogenesis and anti-angiogenesis anti-cancer therapy. , 2008, Mathematical medicine and biology : a journal of the IMA.